| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.57B | -3.3% |
| R&D Expense | $8.1M | +7.1% |
| Pre-tax Income | $693.6M | +13.2% |
| Income Tax | $150.7M | +13.1% |
| Net Income | $542.8M | +13.2% |
| EPS (Basic) | $5.72 | +13.3% |
| EPS (Diluted) | $5.72 | +13.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.75B | -11.4% |
| Total Assets | $38.46B | -2.8% |
| Total Liabilities | $30.85B | -4.0% |
| Stockholders' Equity | $7.62B | +2.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $549.5M | +16.3% |
| Capital Expenditures | $32.5M | +53.9% |
| Investing Cash Flow | $773.9M | -60.9% |
| Financing Cash Flow | -$1.55B | -64.7% |
| Free Cash Flow | $517.0M | +14.5% |